The purpose of this study was to evaluate the role of osteoprotegerin gene (OPG) polymorphisms as genetic modifiers in the etiology of prostate cancer (PCa) and disease progression. The gene discussed is TNFRSF11B; the disease is posterior cortical atrophy.